Markets:

Overview

News

Currencies

International

Treasuries

Ethos Technologies Inc. - Class A Common Stock (NQ:LIFE)

17.32 -0.38 (-2.12%)

Streaming Delayed Price Updated: 10:32 AM EDT, Jun 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ethos Technologies Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 03, 2023

Via Benzinga

This Company Is Beginning A Pivotal Phase 3 EFZO-FIT™ Study. Could It Be A Much-Needed Treatment For Pulmonary Sarcoidosis? ↗

November 29, 2022

Most people may never have heard of sarcoidosis, an inflammatory disease that affects about 1.2 million people worldwide.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

November 18, 2022

On Friday, 64 companies achieved new lows for the year.

Via Benzinga

aTyr Pharma: Q2 Earnings Insights ↗

August 15, 2022

aTyr Pharma (NASDAQ:LIFE) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Beat Of Life Entertainment- A One Stop Solution For Internet Marketing

October 08, 2022

Internet marketing is the solution for business development in the digitalization era.

Via IssueWire

Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary ↗

September 13, 2022

Via Benzinga

aTyr Pharma Gets FDA Fast Track Status For Systemic Sclerosis Candidate ↗

September 13, 2022

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for aTyr Pharma’s (NASDAQ: LIFE) lead therapeutic candidate, efzofitimod, for the treatment of systemic sclerosis...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 13, 2022

Via Benzinga

NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks ↗

August 16, 2022

Raymond James cut the price target for NexImmune, Inc. (NASDAQ: NEXI) from $12 to $3. NexImmune shares rose 2.4% to $1.29 in pre-market trading.

Via Benzinga

Earnings Scheduled For August 15, 2022 ↗

August 15, 2022

Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.

Via Benzinga

A Preview Of aTyr Pharma's Earnings ↗

August 12, 2022

aTyr Pharma (NASDAQ:LIFE) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. Analysts estimate that aTyr Pharma...

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

August 11, 2022

Via Benzinga

aTyr Pharma Shares Ascend As FDA Grants Fast Track Status To Lung Disease Candidate ↗

August 11, 2022

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to aTyr Pharma’s (NASDAQ: LIFE) lead therapeutic candidate, efzofitimod (ATYR1923), for the treatment of pulmonary...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 11, 2022

Via Benzinga

Snap to $25? Plus This Analyst Cuts Price Target On Amazon.com ↗

July 21, 2022

Keybanc cut the price target for Snap Inc. (NYSE: SNAP) from $27 to $25. Snap is scheduled to release its second-quarter results after the closing bell on Thursday. Snap shares rose 0.3% to $15.55 in...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 13, 2022

Gainers

Via Benzinga

$1.4 Million Bet On This Healthcare Stock? 4 Penny Stocks Insiders are Buying ↗

July 07, 2022

U.S. stock futures traded higher this morning on Thursday after closing slightly higher on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More ↗

May 16, 2022

Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...

Via Benzinga

Earnings Outlook For aTyr Pharma ↗

May 06, 2022

aTyr Pharma (NASDAQ:LIFE) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that aTyr Pharma will...

Via Benzinga

Earnings Scheduled For May 9, 2022 ↗

May 09, 2022

Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 14, 2022

Gainers

Via Benzinga

58 Biggest Movers From Yesterday ↗

March 24, 2022

Gainers Allego N.V. (NYSE: ALLG) shares surged 114.1% to close at $17.73 on Wednesday after the company announced the completion of its merger agreement with Spartan Acquisition...

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

March 23, 2022

Gainers Allego N.V. (NYSE: ALLG) shares jumped 158.5% to $21.41 after the company announced the completion of its merger agreement with Spartan Acquisition Corp., which resulted...

Via Benzinga

A Preview Of aTyr Pharma's Earnings ↗

March 11, 2022

aTyr Pharma (NASDAQ:LIFE) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

3 Stocks Insiders Are Buying ↗

January 19, 2022

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 157.46% to $5.69 during Tuesday's pre-market session. The company's market cap stands at $75.1...

Via Benzinga

Earnings Scheduled For March 14, 2022 ↗

March 14, 2022

Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (...

Via Benzinga

What 6 Analyst Ratings Have To Say About aTyr Pharma ↗

November 11, 2021

Within the last quarter, aTyr Pharma (NASDAQ:LIFE) has observed the follow...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 19, 2021

Gainers Sesen Bio (NASDAQ:SESN) stock mo...

Via Benzinga

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Round 2 of the Cappies is Live! Vote Now.

Ethos Technologies Inc. - Class A Common Stock (NQ:LIFE)

All News about Ethos Technologies Inc. - Class A Common Stock

The Newspapers of New England Family

We continue to need local support from our readers

Round 2 of the Cappies is Live! Vote Now.

Ethos Technologies Inc. - Class A Common Stock (NQ:LIFE)

All News about Ethos Technologies Inc. - Class A Common Stock

Enjoying the Concord Monitor?

Sign in